Q: Hi team,

Grateful for your views on Oncorus (oncr-a). Apparently, the CEO was previously head of oncology at Moderna. Any other favorites for growth in the field of immunotherapy ?

With great appreciation for your work,

Jacques IDS

Q: Do you have any information or an opinion on this US company?

Phil

Q: Hi guys,

I already own PLI (3%) and I purchased BLUE. US last year around $70.00. I sold BLUE in September around $ 105 (happy but now NOT). Your thoughts about getting back in (1%).
Thanks,

Jim